Efficacy and safety of low-dose everolimus in Chinese HR-positive, HER2-negative metastatic breast cancer patients.

被引：1
|
作者：
Shao, Xiying
Zheng, Yabing
Chen, Zhan-Hong
Li, Guangliang
Jia, Wang Xiao
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13035
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of Low-dose Apatinib in Advanced HER2-negative Breast Cancer
    Zeng, Tianyu
    Li, Wei
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
    Shikata, Shohei
    Murata, Takeshi
    Yoshida, Masayuki
    Hashiguchi, Hiromi
    Yoshii, Yukiko
    Ogawa, Ayumi
    Watase, Chikashi
    Shiino, Sho
    Sugino, Hirokazu
    Jimbo, Kenjiro
    Maeshima, Akiko
    Iwamoto, Eriko
    Takayama, Shin
    Suto, Akihiko
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [23] Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
    Shohei Shikata
    Takeshi Murata
    Masayuki Yoshida
    Hiromi Hashiguchi
    Yukiko Yoshii
    Ayumi Ogawa
    Chikashi Watase
    Sho Shiino
    Hirokazu Sugino
    Kenjiro Jimbo
    Akiko Maeshima
    Eriko Iwamoto
    Shin Takayama
    Akihiko Suto
    Scientific Reports, 13
  • [24] Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis
    Chen, Ruiliang
    Yu, Yushuai
    Zhang, Jie
    Song, Chuangui
    Wang, Chuan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (07) : 599 - 611
  • [25] Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
    Park, Yeon Hee
    Im, Seock-Ah
    Park, Kyunghee
    Wen, Ji
    Lee, Kyung-Hun
    Choi, Yoon-La
    Lee, Won-Chul
    Min, Ahrum
    Bonato, Vinicius
    Park, Seri
    Ram, Sripad
    Lee, Dae-Won
    Kim, Ji-Yeon
    Lee, Su Kyeong
    Lee, Won-Woo
    Lee, Jisook
    Kim, Miso
    Kim, Hyun Seon
    Weinrich, Scott L.
    Ryu, Han Suk
    Kim, Tae Yong
    Dann, Stephen
    Kim, Yu-Jin
    Fernandez, Diane R.
    Koh, Jiwon
    Wang, Shuoguo
    Park, Song Yi
    Deng, Shibing
    Powell, Eric
    Ravi, Rupesh Kanchi
    Bienkowska, Jadwiga
    Rejto, Paul A.
    Park, Woong-Yang
    Kan, Zhengyan
    GENOME MEDICINE, 2023, 15 (01)
  • [26] Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
    Yeon Hee Park
    Seock-Ah Im
    Kyunghee Park
    Ji Wen
    Kyung-Hun Lee
    Yoon-La Choi
    Won-Chul Lee
    Ahrum Min
    Vinicius Bonato
    Seri Park
    Sripad Ram
    Dae-Won Lee
    Ji-Yeon Kim
    Su Kyeong Lee
    Won-Woo Lee
    Jisook Lee
    Miso Kim
    Hyun Seon Kim
    Scott L. Weinrich
    Han Suk Ryu
    Tae Yong Kim
    Stephen Dann
    Yu-Jin Kim
    Diane R. Fernandez
    Jiwon Koh
    Shuoguo Wang
    Song Yi Park
    Shibing Deng
    Eric Powell
    Rupesh Kanchi Ravi
    Jadwiga Bienkowska
    Paul A. Rejto
    Woong-Yang Park
    Zhengyan Kan
    Genome Medicine, 15
  • [27] HEALTH UTILITIES FOR PATIENTS WITH HR-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW
    da Silva, Aniceto C.
    Cueto, J.
    Salvo, E. M.
    Samjoo, I. A.
    Law, E. H.
    VALUE IN HEALTH, 2020, 23 : S445 - S445
  • [28] ECONOMIC ASSESSMENT OF RIBOCICLIB FOR THE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER HR-POSITIVE, HER2-NEGATIVE
    Velasquez, M.
    Medina, Bustos L.
    Chacon, Zagarra C.
    Rojas, R.
    VALUE IN HEALTH, 2022, 25 (01) : S84 - S84
  • [29] RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
    Wang, Haibo
    Ma, Li
    Zhang, Yanan
    Wang, Ouchen
    Wei, Zhimin
    Xie, Xiaohong
    Zha, Xiaoming
    Zeng, Jian
    Lv, Qing
    Ren, Yu
    Wang, Huimin
    Du, Furong
    Cao, Shangzhi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors
    Hayama, Shouko
    Nakamura, Rikiya
    Miyaki, Toshiko
    Itami, Makiko
    Yamamoto, Naohito
    BREAST CARE, 2022, 17 (01) : 16 - 23
12345